July 14, 2025

The July 2025 Alverno Laboratories Test Bulletin outlines several key updates. The Soft code for *Mycoplasma hominis/Ureaplasma* Culture has changed from URMHC to MHURC, with no alterations to specimen requirements. Multiple Quest Diagnostics tests have been discontinued and replaced with uncoded Quest referred alternatives, including those related to HLA-B 1502, Narcolepsy HLA-QDB1, and Oxalate testing. Additionally, due to a reagent discontinuation, Alverno will now refer all T3 Uptake testing to Quest Diagnostics, though specimen handling remains unchanged. Lastly, beginning July 21, 2025, Alverno will transition HPV PCR testing to the Abbott Alinity m platform, which will identify 14 high-risk HPV genotypes and provide enhanced differentiation for HPV16, HPV18, HPV45, and others, while maintaining current collection and transport procedures.